IRIS
TORINO, FRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 23.304
AS - Asia 3.661
EU - Europa 3.120
SA - Sud America 491
Continente sconosciuto - Info sul continente non disponibili 297
AF - Africa 74
OC - Oceania 30
Totale 30.977
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 23.120
SG - Singapore 1.522
IT - Italia 1.030
CN - Cina 708
BR - Brasile 401
HK - Hong Kong 369
RU - Federazione Russa 359
VN - Vietnam 348
DE - Germania 321
UA - Ucraina 306
IE - Irlanda 226
FI - Finlandia 189
FR - Francia 174
GB - Regno Unito 156
BD - Bangladesh 149
JP - Giappone 130
CA - Canada 112
NL - Olanda 94
KR - Corea 80
IN - India 70
ID - Indonesia 58
SE - Svezia 55
TR - Turchia 51
AR - Argentina 32
PL - Polonia 32
MX - Messico 30
AT - Austria 28
AU - Australia 27
BE - Belgio 26
CZ - Repubblica Ceca 26
TW - Taiwan 24
IR - Iran 19
ES - Italia 17
ZA - Sudafrica 17
EC - Ecuador 16
MY - Malesia 15
CO - Colombia 14
EG - Egitto 14
AL - Albania 13
GR - Grecia 13
IQ - Iraq 13
NP - Nepal 13
PK - Pakistan 13
SA - Arabia Saudita 13
JM - Giamaica 12
PH - Filippine 12
CH - Svizzera 11
CL - Cile 11
TH - Thailandia 11
MA - Marocco 9
TN - Tunisia 9
VE - Venezuela 9
CR - Costa Rica 8
DZ - Algeria 7
LT - Lituania 7
RO - Romania 7
AE - Emirati Arabi Uniti 6
EU - Europa 6
GT - Guatemala 6
PT - Portogallo 6
UZ - Uzbekistan 6
DK - Danimarca 5
NO - Norvegia 5
PY - Paraguay 5
RS - Serbia 5
AZ - Azerbaigian 4
NG - Nigeria 4
HN - Honduras 3
JO - Giordania 3
KE - Kenya 3
LB - Libano 3
OM - Oman 3
PE - Perù 3
AM - Armenia 2
BB - Barbados 2
BH - Bahrain 2
BW - Botswana 2
CI - Costa d'Avorio 2
ET - Etiopia 2
IL - Israele 2
KG - Kirghizistan 2
MD - Moldavia 2
MN - Mongolia 2
MO - Macao, regione amministrativa speciale della Cina 2
MU - Mauritius 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
BQ - ???statistics.table.value.countryCode.BQ??? 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GA - Gabon 1
Totale 30.675
Salva come PNG Salva come JPEG
Città #
Woodbridge 5.943
Houston 5.081
Wilmington 5.042
Singapore 940
Fairfield 622
Chandler 592
Ashburn 560
Ann Arbor 448
San Jose 435
Council Bluffs 434
Hong Kong 352
Beijing 324
Rome 274
Seattle 265
Jacksonville 249
Dublin 215
Cambridge 206
New York 188
The Dalles 182
Medford 153
Santa Clara 130
Helsinki 115
Los Angeles 112
Dearborn 102
Tokyo 93
Hanoi 87
Buffalo 85
Milan 81
Dallas 75
Lawrence 75
Ho Chi Minh City 72
Boardman 67
Lauterbourg 62
Moscow 62
Chicago 57
Redwood City 55
Jakarta 43
Munich 43
Phoenix 43
San Diego 42
São Paulo 40
Dong Ket 39
London 31
North Bergen 30
Menlo Park 29
Mülheim 27
Nuremberg 27
Montreal 26
Columbus 25
Salt Lake City 25
Toronto 23
Brooklyn 22
Nanjing 22
Naples 22
Warsaw 22
Brno 21
Brussels 21
Amsterdam 20
Springfield 19
Verona 19
Sanayi 18
Denver 17
Miami 17
Norwalk 17
Orem 17
Redondo Beach 17
Escondido 16
Florence 16
Lachine 16
New Kensington 16
University Park 16
Guangzhou 14
Taipei 14
Frankfurt am Main 13
Poplar 13
Turin 13
Vienna 13
Falls Church 12
Lappeenranta 12
Palermo 12
Rio de Janeiro 12
Shanghai 12
Stockholm 12
Tampa 12
Zhengzhou 12
Boston 11
Istanbul 11
Johannesburg 11
Mountain View 11
Philadelphia 11
Belo Horizonte 10
Chennai 10
Da Nang 10
Hefei 10
Kathmandu 10
Kingston 10
Manchester 10
Baltimore 9
Bari 9
Curitiba 9
Totale 25.027
Salva come PNG Salva come JPEG
Nome #
Cultural adaptation and linguistic validation of the Family Decision Making Self Efficacy Scale (FDMSES) 648
Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses. 605
La mutualità nel caregiving: una revisione della letteratura 594
Prometheus: A Project for the Dissemination of Knowledge within the Oncology Network of Piedmont and Aosta Valley. 540
A novel method for monitoring response to chemotherapy based on the detection of circulating cancer cells: a case report 532
Hypothyroidism related to tyrosine kinase inhibitors: an emerging toxic effect of targeted therapy. 501
Thyroid dysfunction as an unintended side effect of anticancer drugs. 500
Focus on Fotemustine 498
Unusual sites of metastatic malignancy: case 1. Cardiac metastasis in hepatocellular carcinoma. 496
A phase II study of neoadjuvant bevacizumab plus capecitabine and concomitant radiotherapy in patients with locally advanced rectal cancer. 494
Poly(ADP-ribose) polymerase inhibitor increases growth inhibition and reduces G2/M cell accumulation induced by temozolomide in malignant glioma cells 491
Circulating tumor cells in colorectal cancer patients 491
Tumor immunotherapy: drug-induced neoantigens (xenogenization) and immune checkpoint inhibitors 481
Medullary thyroid cancer: a promising model for targeted therapy. 474
A rare case of juvenile hypertension: Coexistence of type 2 multiple endocrine neoplasia -related bilateral pheochromocytoma and reninoma in a young patient with ACE gene polymorphism 467
Endocrine side effects induced by immune checkpoint inhibitors. 466
Detection of circulating tumor cells is improved by drug-induced antigen up-regulation: preclinical and clinical studies 465
Computational identification of microRNAs associated to both epithelial to mesenchymal transition and NGAL/MMP-9 pathways in bladder cancer 463
Trastuzumab in combination with gemcitabine and vinorelbine as second-line therapy for HER-2/neu overexpressing metastatic breast cancer. 462
Ipilimumab-induced endocrinopathies: when to start corticosteroids (or not). 457
Somatostatin analogs therapy in gastroenteropancreatic neuroendocrine tumors: current aspects and new perspectives. 456
Prognostic and Predictive Significance of Surrogate Biomarkers of Angiogenesis. 453
Endocrinological side-effects of immune checkpoint inhibitors 453
Efficacy and mucosal toxicity of concomitant chemo-radiotherapy in patients with locally-advanced squamous cell carcinoma of the head-and-neck in the light of a novel mathematical model 452
The contribution of targeted therapy to the neoadjuvant chemoradiation of rectal cancer. 446
Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare disease. 444
Endocrine side effects induced by immune checkpoint inhibitors. 443
Combined effects of 5-fluorouracil, folinic acid and oxaliplatin on the expression of carcinoembryonic antigen in human colon cancer cells: pharmacological basis to develop an active antitumor immunochemotherapy 442
Randomized Phase II Trial of weekly paclitaxel alone versus trastuzumab plus weekly paclitaxel as first-line therapy of patients with Her-2 positive advanced breast cancer. 441
Thyroid Function Abnormalities in Patients Receiving Anticancer Agents. 439
Is hypothyroidism a clinically relevant toxicity of tyrosine kinase inhibitors? 433
Mouse models of medullary thyroid cancer and developing new targeted therapies 432
Chemo-immunotherapy of colorectal carcinoma: preclinical rationale and clinical experience 431
Targeted therapy of breast cancer. 431
Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer. 431
"Occult" ovarian Leydig cell tumor: when laboratory tells more than imaging. 429
Therapy of breast cancer with molecular targeting agents. 427
Testicular and inguinal lymph node metastases of medullary thyroid cancer: a case report and review of the literature. 425
Skin acrometastases in squamous cell carcinoma of the tongue. 421
Therapeutic agents that inhibit angiogenesis. 416
Residual telomerase activity: a marker of cell survival after exposure to gamma radiation in vitro 415
Combined therapy with weekly irinotecan, infusional 5-fluorouracil and the selective COX-2 inhibitor rofecoxib is a safe and effective second-line treatment in metastatic colorectal cancer. 412
Genetic and molecular pathophysiology of medullary thyroid cancer. 404
Clinical utility of lanreotide autogel® in gastroenteropancreatic neuroendocrine tumors 404
Predicting ovarian activity in women affected by early breast cancer: Ameta-analysis-based nomogram 403
Is tailored therapy feasible in oncology? 400
Recognizing menopause in women with amenorrhea induced by cytotoxic chemotherapy for endocrine-responsive early breast cancer. 395
Barriers in the management of cancerrelated pain and strategies to overcome them: findings of a qualitative research involving physicians and nurses in Italy 394
Tailored therapy of colorectal cancer: results, challenges and future directions. 393
Cultural adaptation and linguistic validation of the Family Decision Making Self Efficacy Scale (FDMSES). 382
Chemoprevention in gastrointestinal adenocarcinoma: for few but not for all? 380
Drug-induced xenogenization of tumors: A possible role in the immune control of malignant cell growth in the brain? 378
Combination of antiangiogenic therapy with other anticancer treatment. 365
Failure of a cetuximab/bevacizumab schedule in a patient with metastatic desmoplastic small round-cell tumour refractory to chemotherapy. 364
Effects of mutations in Wnt/β-catenin, hedgehog, Notch and PI3K pathways on GSK-3 activity—Diverse effects on cell growth, metabolism and cancer 361
Molecular targeted therapy of medullary thyroid carcinoma 336
Gut microbiota and cancer: From pathogenesis to therapy 245
Lactobacillus rhamnosus GG: An overview to explore the rationale of its use in cancer 238
Role of Mitotane in Adrenocortical Carcinoma - Review and State of the art 232
Validity and Reliability of the Self-Care of Chronic Illness Inventory and Self-Care Self-Efficacy Scale in Patients Living With Cancer 178
Drug-induced neoantigen: a new horizon in cancer immunotherapy? 176
Abscopal effect and drug-induced xenogenization: a strategic alliance in cancer treatment? 173
Insulin Resistance as a Risk Factor for Cutaneous Melanoma. A Case Control Study and Risk-Assessment Nomograms 169
Cancer management during COVID-19 pandemic: is immune checkpoint inhibitors-based immunotherapy harmful or beneficial? 150
Apoptosis as a Driver of Therapy-Induced Cancer Repopulation and Acquired Cell-Resistance (CRAC): A Simple In Vitro Model of Phoenix Rising in Prostate Cancer 150
Development and content validity of the self-care of oral anticancer agents index 149
Urine LOX-1 and volatilome as promising tools towards the early detection of renal cancer 143
Self-care behaviors in patients with cancer treated with oral anticancer agents: a systematic review 140
Effectiveness of Immunotherapy in Non-Small Cell Lung Cancer Patients with a Diagnosis of COPD: Is This a Hidden Prognosticator for Survival and a Risk Factor for Immune-Related Adverse Events? 136
Psychometric Properties of the Self Care Oral Anticancer Agents Index (SCOAAI) 134
NTRK Gene Fusions in Solid Tumors and TRK Inhibitors: A Systematic Review of Case Reports and Case Series 133
Case Report: Ipilimumab-Induced Panhypophysitis: An Infrequent Occurrence and Literature Review 133
Extracellular volume measured by whole body CT scans predicts chronic cardiotoxicity in breast cancer patients treated with neoadjuvant therapies based on anthracyclines: a retrospective study 131
A systematic review of self-care behaviours among patients with cancer who take oral anticancer agents 130
Development and Content Validity of the Self-Care of Oral Anticancer Agents Index (SCOAAI) 129
Activity of ALK inhibitors in renal cancer with ALK alterations: a systematic review 127
Indirect basal metabolism estimation in tailoring recombinant human TSH administration in patients affected by differentiated thyroid cancer: A hypothesis-generating study 122
A scoping review on the "burned out" or "burnt out" testicular cancer: When a rare phenomenon deserves more attention 122
La Terza Missione dell'Università: formazione e salute 118
Obesity and Breast Cancer: Interaction or Interference with the Response to Therapy? 116
Describing self-care behaviours in cancer patients taking oral anticancer agents 116
Case report: Metastatic melanoma derived from a somatic-type malignant transformation of a mediastinal teratoma treated with immune checkpoint inhibitors 108
Investigating Physical, Social, Emotional, and Health Frailties of Cancer Survivors after Cancer Treatment: The Urgent Call for Tailored Multidisciplinary Survivorship Plans in Italy 107
Predictors of self-care in patients with cancer treated with oral anticancer agents: A systematic review 99
AMBRA1 and SQSTM1 expression pattern in prostate cancer 99
Metabolic reprogramming of castration-resistant prostate cancer cells as a response to chemotherapy 94
Core Outcomes of Self-Care Behaviours in Patients with Breast Cancer Treated with Oral Anticancer Agents: A Systematic Review 93
Self-care behaviours in older adults treated with oral anticancer agents: A qualitative descriptive study 93
Immune-checkpoint inhibitors from cancer to COVID‑19: A promising avenue for the treatment of patients with COVID‑19 93
Bone Metabolism Effects of Medical Therapy in Advanced Renal Cell Carcinoma 92
Immune Response in Vitamin D Deficient Metastatic Colorectal Cancer Patients: A Player That Should Be Considered for Targeted Vitamin D Supplementation 92
Androgen Deprivation Freezes Hormone-Sensitive Prostate Cancer Cells in a Reversible, Genetically Unstable Quasi-Apoptotic State, Bursting into Full Apoptosis upon Poly(ADP-ribose) Polymerase Inhibition 91
MiRNAs and circRNAs for the Diagnosis of Anthracycline-Induced Cardiotoxicity in Breast Cancer Patients: A Narrative Review 90
Caregivers’ contribution to self-care for patients treated with oral anticancer agents: A qualitative descriptive study 89
Unemployment Status Subsequent to Cancer Diagnosis and Therapies: A Systematic Review and Meta-Analysis 88
CN29 Short term effects of self-care behaviours on quality of life for patients on oral anticancer agents 86
Antibody-Drug Conjugates for the Treatment of Renal Cancer: A Scoping Review on Current Evidence and Clinical Perspectives 84
The Role of Histology-Agnostic Drugs in the Treatment of Metastatic Castration-Resistant Prostate Cancer 80
Leveraging knowledge for explainable AI in personalized cancer treatment: challenges and future directions 75
Asymptomatic Hypocalcemia Related to Denosumab Administration in Bone-Metastatic Patient Affected by Colorectal Cancer: A Case Report 72
Totale 30.571
Salva come PNG Salva come JPEG
Categoria #
all - tutte 78.860
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 78.860
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022878 0 74 41 50 35 71 47 43 53 109 64 291
2022/20231.438 137 154 130 158 107 267 82 93 116 23 125 46
2023/2024621 85 34 32 27 48 106 37 32 22 17 16 165
2024/20252.583 87 474 200 135 76 178 222 176 222 344 258 211
2025/20265.174 425 208 474 337 512 201 784 618 545 495 367 208
2026/2027592 347 245 0 0 0 0 0 0 0 0 0 0
Totale 30.977